Skip to main contentSkip to navigationSkip to search
ENZY  
SEK  %
Logotype
ENZY  
SEK  %
Logotype

Media

Press releases

2024

november 7, 2024 - Regulatory press release
Interim report Q3/2024: Focus on developing existing and new markets
september 12, 2024 - Regulatory press release
Enzymatica announces outcome of new rights issue
september 9, 2024 - Regulatory press release
Enzymatica publishes supplementary prospectus
september 5, 2024 - Regulatory press release
Reported results on secondary endpoints from the University of Kent study on ColdZyme® show significant reduction of symptoms, lost training days and viral load
augusti 26, 2024 - Regulatory press release
Publication of prospectus regarding Enzymatica’s rights issue
augusti 16, 2024 - Regulatory press release
Final results from independent clinical study of ColdZyme® show duration of illness lowered by approximately 5 days.
augusti 6, 2024 - Regulatory press release
Bulletin from the extraordinary general meeting of Enzymatica AB (publ) on 6 August 2024
juli 18, 2024 - Regulatory press release
Interim report Q2/2024: Enzymatica builds momentum for expansion
juli 18, 2024 - Regulatory press release
Enzymatica's Board of Directors updates the financial targets
juli 18, 2024 - Regulatory press release
Notice of Extraordinary General Meeting in Enzymatica AB (publ)
juli 18, 2024 - Regulatory press release
Enzymatica’s Board of Directors decides on a new rights issue of approximately SEK 130 million
juni 13, 2024 - Regulatory press release
Interim results from independent clinical study of ColdZyme® show duration of illness lowered by approximately 5 days
maj 7, 2024 - Regulatory press release
Bulletin from annual general meeting of Enzymatica AB (publ) on May 7, 2024
april 25, 2024 - Regulatory press release
Interim report Q1/2024: MDR certification opens up great commercial opportunities
april 9, 2024 - Regulatory press release
Enzymatica publishes annual report for 2023
mars 27, 2024 - Regulatory press release
Notice of Annual General Meeting 2024 in Enzymatica AB (publ)
mars 14, 2024 - Regulatory press release
Enzymatica announces outcome of new rights issue
mars 11, 2024 - Non-regulatory press release
ColdZyme® certified under the new EU medical device regulation (MDR)
februari 19, 2024 - Regulatory press release
Enzymatica publishes information memorandum about rights issue of shares
februari 16, 2024 - Regulatory press release
Enzymatica’s rights issue is secured to 100 percent
Load more